Oncology clinical trials during the COVID-19 outbreak: lessons learnt during the crisis and future opportunities
Starting in the city of Wuhan in China in December 2019, the coronavirus COVID-19 spread through Asia, Europe and US reaching a pandemic scale that paralyzed the entire globe. Thousands of deaths were registered in only a few months. Many activities in- and outside hospitals significantly slowed down, oncology drug development included [1,2].
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Elisa Fontana, Hendrik-Tobias Arkenau Tags: Hot Topic Source Type: research
More News: Cancer | Cancer & Oncology | China Health | Clinical Trials | Coronavirus | COVID-19 | Hospitals | Learning | Lessons | Outbreaks | Pandemics